Primary Site >> Liver Cancer
Gene >> CCL3
|
|
|
|
|
|
|
|
|---|---|---|---|---|---|---|---|
|
Ref: Essential contribution of a chemokine, CCL3, and its receptor, CCR1, to hepatocellular carcinoma progression. PMID: 16284949 Ref: Molecular fingerprinting and autocrine growth regulation of endothelial cells in a murine model of hepatocellular carcinoma. PMID: 16397233 |
Ref: Tumor cell apoptosis induces tumor-specific immunity in a CC chemokine receptor 1- and 5-dependent manner in mice. PMID: 18644849 |
Ref: Involvement of glypican-3 in the recruitment of M2-polarized tumor-associated macrophages in hepatocellular carcinoma. PMID: 19838081 |
Ref: Chemokine CCL3 facilitates the migration of hepatoma cells by changing the concentration intracellular Ca. PMID: 20236357 |
Ref: An immunosuppressive subtype of neutrophils identified in patients with hepatocellular carcinoma. PMID: 23170048 |
Ref: p53-dependent chemokine production by senescent tumor cells supports NKG2D-dependent tumor elimination by natural killer cells. PMID: 24043758 |
Ref: Phase II trial of bortezomib plus doxorubicin in hepatocellular carcinoma (E6202): a trial of the Eastern Cooperative Oncology Group. PMID: 24890858 Ref: Evolution of hepatic steatosis to fibrosis and adenoma formation in liver-specific growth hormone receptor knockout mice. PMID: 25566190 |
Ref: High-dose cyclophosphamide induces specific tumor immunity with concomitant recruitment of LAMP1/CD107a-expressing CD4-positive T cells into tumor sites. PMID: 26116901 Ref: Knockdown of SOX18 inhibits the proliferation, migration and invasion of hepatocellular carcinoma cells. PMID: 26151573 Ref: Serum levels of chemokines CCL4 and CCL5 in cirrhotic patients indicate the presence of hepatocellular carcinoma. PMID: 26270232 |